Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey

Antonin Levy; Lizza E. L. Hendriks; Cecile Le Pechoux; Sally Falk; Benjamin Besse; Silvia Novello; Anne-Marie C. Dingemans; Baktiar Hasan; Martin Reck; Thierry Berghmans; Corinne Faivre-Finn

doi:10.1016/j.lungcan.2019.08.007

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey

Antonin Levy^*, Lizza E. L. Hendriks, Cecile Le Pechoux, Sally Falk, Benjamin Besse, Silvia Novello, Anne-Marie C. Dingemans, Baktiar Hasan, Martin Reck, Thierry Berghmans, Corinne Faivre-Finn,

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	145-147
Number of pages	3
Journal	Lung Cancer
Volume	136
DOIs	https://doi.org/10.1016/j.lungcan.2019.08.007
Publication status	Published - Oct 2019
Event	38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) - Barcelona, SPAIN, Milan, Italy Duration: 26 Apr 2019 → 30 Apr 2019 Conference number: 37

Keywords

Small-cell lung cancer
Limited-stage
Thoracic radiotherapy
Fractionation
THORACIC RADIOTHERAPY
IRRADIATION

Cite this

Levy, A., Hendriks, L. E. L., Le Pechoux, C., Falk, S., Besse, B., Novello, S., Dingemans, A-M. C., Hasan, B., Reck, M., Berghmans, T., Faivre-Finn, C. (2019). Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey. Lung Cancer, 136, 145-147. https://doi.org/10.1016/j.lungcan.2019.08.007

Levy, Antonin ; Hendriks, Lizza E. L. ; Le Pechoux, Cecile ; Falk, Sally ; Besse, Benjamin ; Novello, Silvia ; Dingemans, Anne-Marie C. ; Hasan, Baktiar ; Reck, Martin ; Berghmans, Thierry ; Faivre-Finn, Corinne. / Current management of limited-stage SCLC and CONVERT trial impact : Results of the EORTC Lung Cancer Group survey. In: Lung Cancer. 2019 ; Vol. 136. pp. 145-147.

@article{c624ded4a8854d07a566efeb8c533f25,

title = "Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey",

keywords = "Small-cell lung cancer, Limited-stage, Thoracic radiotherapy, Fractionation, THORACIC RADIOTHERAPY, IRRADIATION",

author = "Antonin Levy and Hendriks, {Lizza E. L.} and {Le Pechoux}, Cecile and Sally Falk and Benjamin Besse and Silvia Novello and Dingemans, {Anne-Marie C.} and Baktiar Hasan and Martin Reck and Thierry Berghmans and Corinne Faivre-Finn",

year = "2019",

month = oct

doi = "10.1016/j.lungcan.2019.08.007",

language = "English",

volume = "136",

pages = "145--147",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier Ireland Ltd",

note = "38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), ESTRO 38 ; Conference date: 26-04-2019 Through 30-04-2019",

}

Current management of limited-stage SCLC and CONVERT trial impact : Results of the EORTC Lung Cancer Group survey. / Levy, Antonin; Hendriks, Lizza E. L.; Le Pechoux, Cecile; Falk, Sally; Besse, Benjamin; Novello, Silvia; Dingemans, Anne-Marie C.; Hasan, Baktiar; Reck, Martin; Berghmans, Thierry; Faivre-Finn, Corinne.

In: Lung Cancer, Vol. 136, 10.2019, p. 145-147.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Current management of limited-stage SCLC and CONVERT trial impact

T2 - 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO)

AU - Levy, Antonin

AU - Hendriks, Lizza E. L.

AU - Le Pechoux, Cecile

AU - Falk, Sally

AU - Besse, Benjamin

AU - Novello, Silvia

AU - Dingemans, Anne-Marie C.

AU - Hasan, Baktiar

AU - Reck, Martin

AU - Berghmans, Thierry

AU - Faivre-Finn, Corinne

N1 - Conference code: 37

PY - 2019/10

Y1 - 2019/10

KW - Small-cell lung cancer

KW - Limited-stage

KW - Thoracic radiotherapy

KW - Fractionation

KW - THORACIC RADIOTHERAPY

KW - IRRADIATION

U2 - 10.1016/j.lungcan.2019.08.007

DO - 10.1016/j.lungcan.2019.08.007

M3 - Article

VL - 136

SP - 145

EP - 147

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

Y2 - 26 April 2019 through 30 April 2019

ER -

Access to Document

10.1016/j.lungcan.2019.08.007